Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Pharma Industry Analysis

UpdatedJul 20, 2025
DataAggregated Company Financials
Companies9
  • 7D-1.2%
  • 3M6.0%
  • 1Y-0.08%
  • YTD4.4%

Over the last 7 days, the Pharma industry has dropped 1.2%, driven by Novartis declining 4.3%. Over the last year, the industry has been flat overall. Earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the Swiss Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 21 Jul 2025CHF 441.5bCHF 119.2bCHF 19.6b24.8x22.5x3.7x
Wed, 18 Jun 2025CHF 446.4bCHF 118.6bCHF 19.2b25.1x23.3x3.8x
Fri, 16 May 2025CHF 426.9bCHF 119.8bCHF 19.4b24.7x22x3.6x
Sun, 13 Apr 2025CHF 393.9bCHF 117.3bCHF 18.4b23.4x21.4x3.4x
Tue, 11 Mar 2025CHF 489.1bCHF 121.6bCHF 19.1b29.5x25.6x4x
Thu, 06 Feb 2025CHF 468.6bCHF 122.5bCHF 19.1b23x24.5x3.8x
Sat, 04 Jan 2025CHF 429.0bCHF 119.6bCHF 21.4b17.9x20x3.6x
Mon, 02 Dec 2024CHF 435.0bCHF 117.8bCHF 21.1b18.6x20.6x3.7x
Wed, 30 Oct 2024CHF 457.1bCHF 116.9bCHF 20.9b19.9x21.8x3.9x
Fri, 27 Sep 2024CHF 454.7bCHF 114.6bCHF 19.3b21.8x23.6x4x
Sun, 25 Aug 2024CHF 472.1bCHF 114.7bCHF 19.3b22.5x24.5x4.1x
Tue, 23 Jul 2024CHF 457.4bCHF 116.9bCHF 20.6b32.7x22.2x3.9x
Thu, 20 Jun 2024CHF 430.5bCHF 115.5bCHF 19.6b33.9x21.9x3.7x
Sat, 18 May 2024CHF 417.8bCHF 113.3bCHF 19.9b40.3x21x3.7x
Mon, 15 Apr 2024CHF 400.4bCHF 112.6bCHF 19.5b36.7x20.5x3.6x
Wed, 13 Mar 2024CHF 391.9bCHF 110.2bCHF 19.7b23.8x19.9x3.6x
Fri, 09 Feb 2024CHF 376.9bCHF 110.0bCHF 19.6b24x19.2x3.4x
Sun, 07 Jan 2024CHF 412.8bCHF 119.3bCHF 18.6b26.8x22.2x3.5x
Tue, 05 Dec 2023CHF 397.9bCHF 120.7bCHF 18.8b24.9x21.1x3.3x
Thu, 02 Nov 2023CHF 383.5bCHF 123.1bCHF 19.2b23.6x20x3.1x
Sat, 30 Sep 2023CHF 407.6bCHF 113.6bCHF 18.2b44.5x22.4x3.6x
Mon, 28 Aug 2023CHF 405.7bCHF 112.0bCHF 17.9b47.7x22.6x3.6x
Wed, 26 Jul 2023CHF 419.8bCHF 114.2bCHF 19.2b37.8x21.9x3.7x
Fri, 23 Jun 2023CHF 422.1bCHF 115.2bCHF 18.9b37.6x22.4x3.7x
Sun, 21 May 2023CHF 434.9bCHF 115.3bCHF 18.9b39.9x23x3.8x
Tue, 18 Apr 2023CHF 436.3bCHF 115.0bCHF 18.8b42.3x23.2x3.8x
Thu, 16 Mar 2023CHF 385.4bCHF 116.6bCHF 19.1b25.6x20.2x3.3x
Sat, 11 Feb 2023CHF 407.7bCHF 116.2bCHF 19.0b29.1x21.4x3.5x
Mon, 09 Jan 2023CHF 438.3bCHF 117.3bCHF 34.7b22.5x12.6x3.7x
Wed, 07 Dec 2022CHF 447.4bCHF 117.9bCHF 34.9b23.2x12.8x3.8x
Fri, 04 Nov 2022CHF 462.3bCHF 121.0bCHF 36.3b23.4x12.7x3.8x
Sun, 02 Oct 2022CHF 443.3bCHF 120.6bCHF 37.0b20.2x12x3.7x
Tue, 30 Aug 2022CHF 445.3bCHF 120.0bCHF 36.7b21.1x12.1x3.7x
Thu, 28 Jul 2022CHF 461.1bCHF 119.7bCHF 36.6b28x12.6x3.9x
Price to Earnings Ratio

12.6x


Total Market Cap: CHF 461.1bTotal Earnings: CHF 36.6bTotal Revenue: CHF 119.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Pharma Industry Price to Earnings3Y Average 20.3x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 22.5x which is higher than its 3-year average PE of 20.3x.
  • The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 19% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market0.78%
Healthcare-0.67%
Pharma-1.18%
Pharma-1.18%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SDZ Sandoz GroupCHF 45.951.9%
+CHF 361.8m		32.4%PS2.4x
GALD Galderma GroupCHF 126.300.9%
+CHF 261.1m		76.7%PE162.6x
DESN Dottikon ES HoldingCHF 320.002.7%
+CHF 117.5m		25.7%PE41.9x
COPN Cosmo PharmaceuticalsCHF 62.001.0%
+CHF 9.6m		-9.4%PE8x

Latest News

NOVN
CHF 91.55
Novartis
7D
-5.1%
1Y
-5.0%
GALD
CHF 126.30
Galderma Group
7D
0.9%
1Y
76.7%
SDZ
CHF 45.95
Sandoz Group
7D
1.9%
1Y
32.4%

Sentiment Still Eluding Sandoz Group AG (VTX:SDZ)

Jun 25
Sentiment Still Eluding Sandoz Group AG (VTX:SDZ)
ROG
CHF 255.60
Roche Holding
7D
-0.8%
1Y
-8.7%

These 4 Measures Indicate That Roche Holding (VTX:ROG) Is Using Debt Reasonably Well

Jun 24
These 4 Measures Indicate That Roche Holding (VTX:ROG) Is Using Debt Reasonably Well
ADXN
CHF 0.058
Addex Therapeutics
7D
-2.0%
1Y
-6.5%
DESN
CHF 320.00
Dottikon ES Holding
7D
2.7%
1Y
25.7%

Here's Why Dottikon ES Holding (VTX:DESN) Has Caught The Eye Of Investors

Jun 18
Here's Why Dottikon ES Holding (VTX:DESN) Has Caught The Eye Of Investors
COPN
CHF 62.00
Cosmo Pharmaceuticals
7D
1.0%
1Y
-9.4%
CURN
CHF 10.90
Curatis Holding
7D
-0.5%
1Y
81.7%
NWRN
CHF 6.70
Newron Pharmaceuticals
7D
-3.9%
1Y
-15.1%